Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DoD Validation of Multidrug-Resistant Tuberculosis Diagnostic in Peru

by Global Biodefense Staff
July 16, 2013

The Naval Medical Research Center this week posted a solicitation for contract support to implement a Peru-based study entitled “Validation of new multidrug resistant tuberculosis (MDR-TB) diagnostic tools in diverse setting.”

The requirements of the contract include:

Manufacturing and providing the new Colour Test for diagnosing MDR-TB for the study
Assisting with the technical training at the research sites in both Iquitos and Lima to include the development of the standard operating procedure for the processing of the sputum samples collected for testing
Assisting in the logistical support at both the Lima and Iquitos site to include the shipping of samples to the TB lab at Universidad Peruana Cayetano Heredia in Lima for testing
Perform and validate the testing of sputum samples collected within the study by comparing the Xpert® MTB/RIF assay (by Cephid, Inc., Sunnyvale, CA, USA), the “Colour Test” (a colorimetric agar culture test), and the BACTECTM Mycobacterium Growth Indicator Tube (MGIT) test (by Becton Dickinson Microbiology Systems, Sparks, MD, USA) with drug susceptibility testing (DST) when the MGIT is positive for M. tuberculosis
Perform up to 2 pilot technical assessment visits at 2 potential overseas sites
Assist in the preparation of scientific publications that are generated from this study

The contract is for a one-year project starting in August 2013. The requirement is also being advertised to local vendors in Peru through the newspaper PERU21.

Further details are available under Solicitation Number: N44852_TBCOLORTEST. The response deadline is July 27, 2013.

Tags: Tuberculosis

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC